Your Messages Inbox
Your Article Summary
See Latest ArticlesGSK’s paediatric pneumococcal candidate vaccine Synflorix receives positive opinion in Europe
GlaxoSmithKline, 01/23/09
GlaxoSmithKline (GSK) announced that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP)has issued a positive opinion and recommends approval of GSK’s paediatric pneumococcal candidate vaccine Synflorix. The paediatric vaccine is proposed to be indicated for active immunisation against invasive pneumococcal disease (IPD) and middle ear infections caused by Streptococcus pneumoniae in infants and children from 6 weeks up to 2 years. The European Marketing Authorisation for the vaccineis expected to be granted in the coming months.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor